Yan‐Fang Xian

3.8k total citations
97 papers, 3.0k citations indexed

About

Yan‐Fang Xian is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Yan‐Fang Xian has authored 97 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 29 papers in Pharmacology and 25 papers in Physiology. Recurrent topics in Yan‐Fang Xian's work include Alzheimer's disease research and treatments (17 papers), Dermatology and Skin Diseases (9 papers) and Tryptophan and brain disorders (8 papers). Yan‐Fang Xian is often cited by papers focused on Alzheimer's disease research and treatments (17 papers), Dermatology and Skin Diseases (9 papers) and Tryptophan and brain disorders (8 papers). Yan‐Fang Xian collaborates with scholars based in Hong Kong, China and United States. Yan‐Fang Xian's co-authors include Zhi‐Xiu Lin, Siu‐Po Ip, Ziren Su, Qing‐Qiu Mao, Xiao‐Ping Lai, Chun‐Tao Che, Wen Yang, Qingqing Xu, Jianhui Xie and Jiannan Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Free Radical Biology and Medicine.

In The Last Decade

Yan‐Fang Xian

91 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yan‐Fang Xian Hong Kong	34	1.3k	670	532	467	453	97	3.0k
Zhi‐Xiu Lin Hong Kong	40	2.0k 1.6×	599 0.9×	591 1.1×	591 1.3×	436 1.0×	150	4.1k
Chandragouda R. Patil India	30	1.0k 0.8×	460 0.7×	439 0.8×	383 0.8×	670 1.5×	97	3.4k
Tianhua Yan China	32	1.7k 1.4×	449 0.7×	511 1.0×	349 0.7×	320 0.7×	71	3.2k
Tina Ting-Xia Dong Hong Kong	36	1.7k 1.3×	520 0.8×	570 1.1×	314 0.7×	899 2.0×	136	3.4k
Weiwei Tao China	34	1.5k 1.2×	574 0.9×	437 0.8×	202 0.4×	397 0.9×	117	3.2k
Siu‐Po Ip Hong Kong	42	1.6k 1.3×	1.1k 1.6×	805 1.5×	546 1.2×	716 1.6×	117	4.3k
Qiusheng Zheng China	38	1.9k 1.5×	811 1.2×	425 0.8×	295 0.6×	373 0.8×	165	3.8k
Chi‐Rei Wu Taiwan	32	1.2k 1.0×	371 0.6×	684 1.3×	348 0.7×	582 1.3×	95	3.0k
Sushruta Koppula South Korea	29	1.1k 0.9×	319 0.5×	395 0.7×	358 0.8×	549 1.2×	122	3.0k
Mohammed M. Safhi Saudi Arabia	28	696 0.6×	395 0.6×	397 0.7×	432 0.9×	595 1.3×	62	2.6k

Countries citing papers authored by Yan‐Fang Xian

Since Specialization

Citations

This map shows the geographic impact of Yan‐Fang Xian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan‐Fang Xian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan‐Fang Xian more than expected).

Fields of papers citing papers by Yan‐Fang Xian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan‐Fang Xian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan‐Fang Xian. The network helps show where Yan‐Fang Xian may publish in the future.

Co-authorship network of co-authors of Yan‐Fang Xian

This figure shows the co-authorship network connecting the top 25 collaborators of Yan‐Fang Xian. A scholar is included among the top collaborators of Yan‐Fang Xian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan‐Fang Xian. Yan‐Fang Xian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Zhihao, Xinyue Li, Yong Zhu, et al.. (2025). Exploring the Protective Effects of Schisandrin A and Schisandrin B Against Diabetic Cardiomyopathy With a Possible Mechanism Involving Complement Inhibition. Phytotherapy Research. 39(12). 5506–5520.

Liu, Yanfei, Yanfei Liu, Qing Wang, et al.. (2024). Gut microbiota in combination with blood metabolites reveals characteristics of the disease cluster of coronary artery disease and cognitive impairment: a Mendelian randomization study. Frontiers in Immunology. 14. 1308002–1308002. 4 indexed citations

Zhang, Juan, Yulin Wu, Hong‐Xi Xu, et al.. (2024). Brusatol alleviates pancreatic carcinogenesis via targeting NLRP3 in transgenic Krastm4Tyj Trp53tm1Brn Tg (Pdx1-cre/Esr1*) #Dam mice. Biomedicine & Pharmacotherapy. 177. 116977–116977. 2 indexed citations

Xu, Qingqing, et al.. (2024). Tianma-Gouteng pair ameliorates the cognitive deficits on two transgenic mouse models of Alzheimer's disease. Journal of Ethnopharmacology. 328. 118113–118113. 5 indexed citations

Xu, Qingqing, Ziren Su, Wen Yang, et al.. (2023). Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer’s disease via modulating neuropathology and gut microbiota through suppressing C/EBPβ/AEP pathway. Journal of Neuroinflammation. 20(1). 19–19. 50 indexed citations

Wang, Lan, Zhen Hu, Wen Yang, et al.. (2022). Anti-atopic dermatitis effect of a modified Huang-Lian-Jie-Du decoction and its active fraction on 2,4-dinitrobenzene and MC903-induced mouse models. Phytomedicine. 104. 154346–154346. 15 indexed citations

Xu, Qingqing, Ziren Su, Zhen Hu, et al.. (2022). Patchouli alcohol ameliorates the learning and memory impairments in an animal model of Alzheimer's disease via modulating SIRT1. Phytomedicine. 106. 154441–154441. 16 indexed citations

Huang, Qionghui, Juan Zhang, William C. Cho, et al.. (2022). Brusatol suppresses the tumor growth and metastasis of colorectal cancer via upregulating ARRDC4 expression through modulating PI3K/YAP1/TAZ Pathway. Phytomedicine. 109. 154567–154567. 11 indexed citations

Qu, Chang, Qiaoping Li, Ziren Su, et al.. (2021). Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer’s disease via inhibiting neuropathology and modulating gut microbiota. Journal of Advanced Research. 35. 231–243. 62 indexed citations

10.

Yang, Wen, Yue Liu, Qingqing Xu, Yan‐Fang Xian, & Zhi‐Xiu Lin. (2020). Sulforaphene Ameliorates Neuroinflammation and Hyperphosphorylated Tau Protein via Regulating the PI3K/Akt/GSK-3βPathway in Experimental Models of Alzheimer’s Disease. Oxidative Medicine and Cellular Longevity. 2020. 1–17. 143 indexed citations

11.

Xian, Yan‐Fang, Chang Qu, Yue Liu, et al.. (2020). Magnolol Ameliorates Behavioral Impairments and Neuropathology in a Transgenic Mouse Model of Alzheimer’s Disease. Oxidative Medicine and Cellular Longevity. 2020. 1–17. 35 indexed citations

12.

Hu, Shengquan, Yan‐Fang Xian, Yubo Fan, et al.. (2020). Significant combination of Aβ aggregation inhibitory and neuroprotective properties in silico, in vitro and in vivo by bis(propyl)-cognitin, a multifunctional anti-Alzheimer’s agent. European Journal of Pharmacology. 876. 173065–173065. 9 indexed citations

13.

Zhang, Zhenbiao, Siu‐Po Ip, William C. Cho, et al.. (2020). Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models. Journal of Ethnopharmacology. 260. 113058–113058. 15 indexed citations

14.

Li, Huiqin, Siu‐Po Ip, Qiuju Yuan, et al.. (2019). Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer’s disease. Brain Behavior and Immunity. 82. 264–278. 50 indexed citations

15.

Li, Cailan, Gaoxiang Ai, Yongfu Wang, et al.. (2019). Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway. Pharmacological Research. 152. 104603–104603. 211 indexed citations

16.

Mo, Zhi‐Zhun, Zhi‐Xiu Lin, Ziren Su, et al.. (2018). Angelica sinensis Supercritical Fluid CO ₂ Extract Attenuates D-Galactose-Induced Liver and Kidney Impairment in Mice by Suppressing Oxidative Stress and Inflammation. Journal of Medicinal Food. 21(9). 887–898. 27 indexed citations

17.

Xian, Yan‐Fang, Zhi‐Xiu Lin, Xinyi Xu, et al.. (2012). Effect of Rhizoma Polygonati on 12-O-tetradecanoylphorbol-acetate-induced ear edema in mice. Journal of Ethnopharmacology. 142(3). 851–856. 27 indexed citations

18.

Ip, Siu‐Po, et al.. (2012). Impact of the Herbal Medicine Sophora flavescens on the Oral Pharmacokinetics of Indinavir in Rats: The Involvement of CYP3A and P-Glycoprotein. PLoS ONE. 7(2). e31312–e31312. 21 indexed citations

19.

Xian, Yan‐Fang, Yucui Li, Siu‐Po Ip, et al.. (2011). Anti-inflammatory effect of patchouli alcohol isolated from Pogostemonis Herba in LPS-stimulated RAW264.7 macrophages. Experimental and Therapeutic Medicine. 2(3). 545–550. 90 indexed citations

20.

Mao, Qing‐Qiu, Yan‐Fang Xian, Siu‐Po Ip, & Chun‐Tao Che. (2011). Involvement of serotonergic system in the antidepressant-like effect of piperine. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(4). 1144–1147. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact